Vergent Shows Abenacianine Boosts Tumor Visibility in Surgery
22 May 2025 //
BUSINESSWIRE
Vergent Bioscience to Present Abenacianine Data at 2025 ASCO Meet
08 May 2025 //
BUSINESSWIRE
Vergent Bio Completes Phase 2 Trial Enrollment for Abenacianine
13 Nov 2024 //
BUSINESSWIRE
Vergent`s VGT-309 Shows Promise In Lung Tumor Visualization
18 Jul 2024 //
BUSINESSWIRE
Vergent Initiates Phase 2 Study Evaluating VGT-309
13 Dec 2023 //
BUSINESSWIRE
Vergent Bioscience shares Phase IIb plans for oncology imaging agent
03 Nov 2022 //
CLINICALTRIALSARENA

Market Place
Sourcing Support